These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8211208)

  • 1. Immunobiologic correlates of prognosis in lymphoma.
    Grogan TM; Miller TP
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):58-74. PubMed ID: 8211208
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocytic leukemia and lymphomas.
    Drexler HG; Minowada J
    Immunol Ser; 1990; 53():243-64. PubMed ID: 2100558
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
    Glasová M; Koníková E; Stasáková J; Babusíková O
    Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of adhesion molecules LFA-1, ICAM-1, CD44, and L-selectin in childhood non-Hodgkin lymphomas.
    Yaris N; Büyükpamukçu M; Kansu E; Canpinar H
    Med Pediatr Oncol; 2001 Mar; 36(3):359-64. PubMed ID: 11241437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
    Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
    Muenst S; Hoeller S; Dirnhofer S; Tzankov A
    Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent insights on the pathogenesis of non-Hodgkin's lymphoma].
    Gaidano G; Gloghini A; Pastore C; Carbone A
    Pathologica; 1995 Dec; 87(6):595-602. PubMed ID: 8927418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemic phase of mantle cell lymphoma presenting as anemia: diagnosis by combining flow cytometry and cytomorphology.
    Brink DS; Grosso LE; Dunphy CH
    Arch Pathol Lab Med; 1998 Nov; 122(11):1018-22. PubMed ID: 9822132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunophenotyping in the diagnosis of non-Hodgkin lymphomas: a literature review].
    Rauh S; Duhem C; Mahassen P; Ries F; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1996; 133(2):27-33. PubMed ID: 9064220
    [No Abstract]   [Full Text] [Related]  

  • 11. Hodgkin disease with subsequent transformation to CD30 positive non-hodgkin lymphoma in six patients.
    Mori N; Watanabe K; Yamashita Y; Nakayama A; Yatabe Y; Narita M; Kobayashi T; Hasegawa Y; Kojima H; Nagasawa T
    Cancer; 1999 Feb; 85(4):970-9. PubMed ID: 10091777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stages of lymphoid tissue ontogenesis and histogenesis of non-Hodgkin lymphoma].
    Krivolanov IuA
    Vopr Onkol; 2005; 51(4):417-26. PubMed ID: 16308972
    [No Abstract]   [Full Text] [Related]  

  • 13. [T-cell-rich B-cell lymphoma: multifactorial study of 4 cases].
    Moreno MM; Fernández-Flores A; Paradela A; Rodríguez JM; Ageitos A; Gonzalo I; Marcos B; Robledo M; Rivas C
    Sangre (Barc); 1995 Dec; 40(6):471-7. PubMed ID: 8850230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetics of indolent lymphomas.
    Mrózek K; Bloomfield CD
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):47-57. PubMed ID: 8211207
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinicopathologic and immunohistochemical study of primary non-Hodgkin lymphoma of the female genital system].
    Jiang XF; Yang KX; Peng ZL; Xu L; Huang Q; Li Q
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):222-6. PubMed ID: 17631759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor markers in malignant lymphoma].
    Kato H; Ogura M
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic transformation of mantle cell lymphoma.
    Kaleem Z; Wakoff AR; Smith RP; Hess JL
    Arch Pathol Lab Med; 1996 Jun; 120(6):577-80. PubMed ID: 8651861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and prognostic value of the immunohistochemical study of proliferating cell nuclear antigen (PCNA) expression in paraffin sections from non-hodgkin's lymphoma].
    Gómez Arbonés X; Campo Güerri E; Virgili JM; Panades Siurana MJ
    Sangre (Barc); 1995 Dec; 40(6):520-1. PubMed ID: 8850240
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinically relevant prognostic factors in malignant lymphoma].
    Engelhard M; Löffler M
    Internist (Berl); 1993 Feb; 34(2):127-31. PubMed ID: 8454425
    [No Abstract]   [Full Text] [Related]  

  • 20. [Centrocytic lymphoma developing into leukemic immunoblastic lymphoma. Immunohistochemical demonstration of monoclonality].
    Scolozzi R; Boccafogli A; Cavazzini L; Altavilla G; Guidoboni CA; Vicentini L; Salmi R; Coletti M
    Haematologica; 1984; 69(2):227-31. PubMed ID: 6429008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.